STOCK TITAN

NYXOAH S A Stock Price, News & Analysis

NYXH Nasdaq

Welcome to our dedicated page for NYXOAH S A news (Ticker: NYXH), a resource for investors and traders seeking the latest updates and insights on NYXOAH S A stock.

Nyxoah SA (NYSE: NYXH) is a pioneering health technology company focused on innovative treatments for sleep disordered breathing, particularly Obstructive Sleep Apnea (OSA). This page serves as the definitive source for official updates about their FDA-cleared Genio neurostimulation system, financial developments, and clinical research progress.

Investors and medical professionals will find curated press releases covering regulatory milestones, partnership announcements, and quarterly earnings reports. All content is sourced directly from company filings and verified channels to ensure accuracy.

Key focus areas include updates about international market expansions, clinical trial outcomes for OSA therapies, and technological enhancements to the Genio platform. Bookmark this page to stay informed about Nyxoah's progress in developing patient-centric solutions for chronic sleep conditions.

Rhea-AI Summary

Nyxoah (Euronext Brussels/Nasdaq: NYXH), a medical technology company, will release its Q1 2024 financial results on May 14, 2024, after the market closes. The announcement will be followed by a conference call at 10:30pm CET / 4:30pm ET to discuss the results.

The webcast of the call can be accessed via the Nyxoah Investor Relations page. Pre-registration is required for those wishing to ask questions during the call, with an email providing dial-in details and a unique access code for the live call to follow. The webcast will be available for replay shortly after the event concludes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.25%
Tags
-
Rhea-AI Summary

The press release announces the invitation to attend the annual and extraordinary shareholders' meetings of NYXOAH SA, a company listed on Euronext Brussels under the symbol NYXH, to be held on June 12, 2024. The meetings will address various agenda items including approval of financial statements, discharge of directors and auditors, approval of remuneration report, and appointment of directors. Shareholders can participate in person or via video conference by following specified registration and voting procedures. The press release provides detailed information on formalities, participation requirements, voting procedures, and data processing related to the meetings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.4%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.3%
Tags
management
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.12%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.88%
Tags
partnership
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.92%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.33%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.07%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.3%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.47%
Tags
none

FAQ

What is the current stock price of NYXOAH S A (NYXH)?

The current stock price of NYXOAH S A (NYXH) is $8.22 as of July 18, 2025.

What is the market cap of NYXOAH S A (NYXH)?

The market cap of NYXOAH S A (NYXH) is approximately 289.8M.
NYXOAH S A

Nasdaq:NYXH

NYXH Rankings

NYXH Stock Data

289.75M
21.82M
38.32%
33%
0.27%
Medical Instruments & Supplies
Healthcare
Link
Belgium
Mont-Saint-Guibert